MedTrace Logo

Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)

NCT02421757 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-11-23

Study results available
· View outcomes & findings →

Summary

This is a single-site, randomized, Single-blinded, placebo-controlled, trial of Transcutaneous Magnetic Stimulation (TCMS) for the treatment of lower back pain. TCMS will be applied locally to the back in the location of a patient's pain.

Conditions

  • Lower Back Pain

Interventions

DEVICE

Fischell Transcutaneous Magnetic Stimulation Pain Treatment Device

Transcutaneous Magnetic Stimulation

DEVICE

Placebo

The placebo Transcutaneous device

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Peter Rock, MD · University of Maryland, Baltimore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-22
Primary Completion
2017-06-22
Completion
2017-06-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02421757 on ClinicalTrials.gov